ImageVerifierCode 换一换
格式:PDF , 页数:18 ,大小:339.33KB ,
资源ID:723584      下载积分:10000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-723584.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(EN ISO 8871-3-2004 en Elastomeric parts for parenterals and for devices for pharmaceuticals use - Part 3 Determination of released-particle count《非肠道及制药设备用弹性件 第3部分 测定释放粒子数量(ISO 887.pdf)为本站会员(sumcourage256)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

EN ISO 8871-3-2004 en Elastomeric parts for parenterals and for devices for pharmaceuticals use - Part 3 Determination of released-particle count《非肠道及制药设备用弹性件 第3部分 测定释放粒子数量(ISO 887.pdf

1、BRITISH STANDARD BS EN ISO 8871-3:2004 Elastomeric parts for parenterals and for devices for pharmaceuticals use Part 3: Determination of released-particle count The European Standard EN ISO 8871-3:2004 has the status of a British Standard ICS 11.040.20 BS EN ISO 8871-3:2004 This British Standard wa

2、s published under the authority of the Standards Policy and Strategy Committee on 9 June 2004 BSI 9 June 2004 ISBN 0 580 43870 8 National foreword This British Standard is the official English language version of EN ISO 8871-3:2004. It is identical with ISO 8871-3:2003. It partially supersedes BS EN

3、 ISO 8871:1997 which will be withdrawn on publication of BS EN ISO 8871 Parts 1 and 2. The UK participation in its preparation was entrusted to Technical Committee CH/212, IVDs, which has the responsibility to: A list of organizations represented on this committee can be obtained on request to its s

4、ecretary. Cross-references The British Standards which implement international or European publications referred to in this document may be found in the BSI Catalogue under the section entitled “International Standards Correspondence Index”, or by using the “Search” facility of the BSI Electronic Ca

5、talogue or of British Standards Online. This publication does not purport to include all the necessary provisions of a contract. Users are responsible for its correct application. Compliance with a British Standard does not of itself confer immunity from legal obligations. aid enquirers to understan

6、d the text; present to the responsible international/European committee any enquiries on the interpretation, or proposals for change, and keep the UK interests informed; monitor related international and European developments and promulgate them in the UK. Summary of pages This document comprises a

7、front cover, an inside front cover, the EN ISO title page, the EN ISO foreword page, the ISO title page, pages ii to v, a blank page, pages 1 to 6, an inside back cover and a back cover. The BSI copyright notice displayed in this document indicates when the document was last issued. Amendments issue

8、d since publication Amd. No. Date CommentsEUROPEANSTANDARD NORMEEUROPENNE EUROPISCHENORM ENISO88713 May2004 ICS11.040.20 SupersedesENISO8871:1997 Englishversion Elastomericpartsforparenteralsandfordevicesfor pharmaceuticalsusePart3:Determinationofreleasedparticle count(ISO88713:2003) lmentsenlastomr

9、epouradministrationparentraleet dispositifsusagepharmaceutiquePartie3: Dnombrementdesparticuleslibres(ISO88713:2003) ElastomereTeilefrParenteraliaundfrGertezur pharmazeutischenVerwendungTeil3:Bestimmungvon herausgelstenPartikeln(ISO88713:2003) ThisEuropeanStandardwasapprovedbyCENon1April2004. CENmem

10、bersareboundtocomplywiththeCEN/CENELECInternalRegulationswhichstipulatetheconditionsforgivingthisEurope an Standardthestatusofanationalstandardwithoutanyalteration.Uptodatelistsandbibliographicalreferencesconcernings uchnational standardsmaybeobtainedonapplicationtotheManagementCentreortoanyCENmembe

11、r. ThisEuropeanStandardexistsinthreeofficialversions(English,French,German).Aversioninanyotherlanguagemadebytra nslation undertheresponsibilityofaCENmemberintoitsownlanguageandnotifiedtotheManagementCentrehasthesamestatusasthe official versions. CENmembersarethenationalstandardsbodiesofAustria,Belgi

12、um,Cyprus,CzechRepublic,Denmark,Estonia,Finland,France, Germany,Greece,Hungary,Iceland,Ireland,Italy,Latvia,Lithuania,Luxembourg,Malta,Netherlands,Norway,Poland,Portugal, Slovakia, Slovenia,Spain,Sweden,SwitzerlandandUnitedKingdom. EUROPEANCOMMITTEEFORSTANDARDIZATION COMITEUROPENDENORMALISATION EURO

13、PISCHESKOMITEEFRNORMUNG ManagementCentre:ruedeStassart,36B1050Brussels 2004CEN Allrightsofexploitationinanyformandbyanymeansreserved worldwideforCENnationalMembers. Ref.No.ENISO88713:2004EForeword ThetextofISO88713:2003hasbeenpreparedbyTechnicalCommitteeISO/TC76 “Transfusion,infusionandinjectionequi

14、pmentformedicalandpharmaceuticaluse“ofthe InternationalOrganizationforStandardization(ISO)andhasbeentakenoverasENISO8871 3:2004byCMC. ThisEuropeanStandardshallbegiventhestatusofanationalstandard,eitherbypublicationof anidenticaltextorbyendorsement,atthelatestbyNovember2004,andconflictingnational sta

15、ndardsshallbewithdrawnatthelatestbyNovember2004. ThisdocumentsupersedesENISO8871:1997. AccordingtotheCEN/CENELECInternalRegulations,thenationalstandardsorganizationsof thefollowingcountriesareboundtoimplementthisEuropeanStandard:Austria,Belgium, Cyprus,CzechRepublic,Denmark,Estonia,Finland,France,Ge

16、rmany,Greece,Hungary, Iceland,Ireland,Italy,Latvia,Lithuania,Luxembourg,Malta,Netherlands,Norway,Poland, Portugal,Slovakia,Slovenia,Spain,Sweden,SwitzerlandandUnitedKingdom. Endorsementnotice ThetextofISO88713:2003hasbeenapprovedbyCENasENISO88713:2004withoutany modifications. ENISO88713:2004 Referen

17、ce number ISO 8871-3:2003(E)INTERNATIONAL STANDARD ISO 8871-3 First edition 2003-08-01 Elastomeric parts for parenterals and for devices for pharmaceutical use Part 3: Determination of released-particle count lments en lastomre pour administration parentrale et dispositifs usage pharmaceutique Parti

18、e 3: Dnombrement des particules libres ENISO88713:2004DPlcsid Fremia ihTs PDF file mya ctnoian emdebt dedyfepcaes. In ccacnadrow eitA hebods licnesilop gnic,y tihs file mirp eb yatnde iv roweb detu slahl ton ide ebtlnu deess teh typfecaes wihce era hml era deddebicsnede ti dna onstlalde t noeh comup

19、tfrep reromign tide ehtin.g In wodlnidaot gnihs fil,e trapise atpecc tiereht nser ehnopsiiblity fo nto ifnriigngn Aebods licnesilop gnic.y ehT ISO tneClar Secrteirata caceptl on siibality in this .aera Ai ebods a tedarmfo kra Aebod SystemI snctaropro.de teDials fo teh sfotwcudorp erats sut deo crtae

20、e tihs PDF file cna f ebi dnuon tlareneG eh Ifnler oatit evt oeh file; tP ehDc-Frtaeino marapterew stpo ereimizde fro irptni.gn Evyre cera neeb sah takne tsne oeru taht teh file is siutlbae fosu re yb ISO memdob rebeis. In tlnu ehikletneve y ttah lborp aem lertait gno it is f,dnuo plsaee ifnrom ttne

21、C ehlar Secterirata ta teh serddaig sleb nevwo. ISO 3002 All irthgs erse.devr lnUeto sswrehise specified, on trap fo this lbupictaion maeb y cudorperro de tuilizi den yna form ro na ybm ynae,s lecetrinoc ro mceinahcla, incliduntohp gcoiypodna gn micrfoilm, wittuoh repmissii now nritign from ietI reh

22、Sa Ot tsserdda eh ebolw or ISOs memreb i ydobn the cnuotfo yr ttseuqer ehe.r ISO cirypothg fofice saCe tsopale 65 eneG 1121-HC 02 av leT. 4 + 10 947 22 1 11 xaF0 947 22 14 + 9 74 E-mial coirypthgis.o gro We bwww.is.o groii ENISO88713:2004 iiiContents Page Foreword iv Introduction v 1 Scope 1 2 Norma

23、tive references . 1 3 Determination of visible-particle count 1 4 Determination of subvisible-particle count 3 Bibliography . 6 ENISO88713:2004iv Foreword ISO (the International Organization for Standardization) is a worldwide federation of national standards bodies (ISO member bodies). The work of

24、preparing International Standards is normally carried out through ISO technical committees. Each member body interested in a subject for which a technical committee has been established has the right to be represented on that committee. International organizations, governmental and non-governmental,

25、 in liaison with ISO, also take part in the work. ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization. International Standards are drafted in accordance with the rules given in the ISO/IEC Directives, Part 2. The main t

26、ask of technical committees is to prepare International Standards. Draft International Standards adopted by the technical committees are circulated to the member bodies for voting. Publication as an International Standard requires approval by at least 75 % of the member bodies casting a vote. Attent

27、ion is drawn to the possibility that some of the elements of this document may be the subject of patent rights. ISO shall not be held responsible for identifying any or all such patent rights. ISO 8871-3 was prepared by Technical Committee ISO/TC 76, Transfusion, infusion and injection equipment for

28、 medical and pharmaceutical use. Together with the other parts (see below), this part of ISO 8871 cancels and replaces ISO 8871:1990, which has been technically revised. ISO 8871 consists of the following parts, under the general title Elastomeric parts for parenterals and for devices for pharmaceut

29、ical use: Part 1: Extractables in aqueous autoclavates Part 2: Identification and characterization Part 3: Determination of released-particle count Part 4: Biological requirements and test methods Part 5: Functional requirements and testing ENISO88713:2004 vIntroduction When elastomeric closures are

30、 used as primary packaging materials in direct contact with pharmaceutical preparations, the pharmaceutical industry requires, to an increasing extent, definite details from the rubber manufacturer about the presence of particles the closures may release into an injectable. The test methods specifie

31、d in Clauses 3 and 4 make it possible to meet this request. ENISO88713:2004INTENRATIONAL TSANDADR IS-1788 O3:(3002E)1Elastomeric parts for parenterals and for devices for pharmaceutical use Part 3: Determination of released-particle count 1 Scope Elastomeric closures may be superficially contaminate

32、d with visible and subvisible particles, and fragments can also be produced when the closure is pierced by a needle. Such particles may be transferred to pharmaceutical preparations in contact with the elastomeric parts and affect the quality of such preparations. This part of ISO 8871 specifies met

33、hods for the determination of the number of visible and subvisible particles, respectively, detached from elastomeric parts by rinsing. It does not specify particle contamination limits. These will have to be agreed upon between manufacturer and user. 2 Normative references The following referenced

34、documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies. ISO 3696:1997, Water for analytical laboratory use Specification and test

35、methods 3 Determination of visible-particle count 3.1 Principle This method evaluates the potential for contamination by collecting and counting the particles detached from elastomeric parts on rinsing with water. 3.2 Classification For the purposes of this method, particles are divided into size cl

36、asses as follows, using the longest dimension as the classifying parameter: Class I: 25 m but u 50 m; Class II: 50 m but u 100 m; Class III: 100 m. ENISO88713:20042 3.3 Apparatus and materials 3.3.1 Shaking machine, moving in a horizontal circle of 12 mm 1 mm diameter at 300 min 1to 350 min 1 . 3.3.

37、2 Membrane filters, with a maximum pore size of 0,8 m, provided with grid lines dividing the surface into 3 mm 3 mm squares. NOTE The colour of the filter may significantly affect the test results. If no specific agreement has been made between the interested parties, the basic colour shall be mediu

38、m grey and lie within the following coordinate ranges in the CIE (International Commission on Illumination) system: L* between 60 % and 70 %; a* between 4,7 % and 3,7 %; b* between 4,7 % and 3,7 %. These specifications apply to the grid-imprinted surface of the filter, and assume this surface has a

39、3-mm- square grid made up of green lines. 3.3.3 Clean, wide-mouthed conical flasks, of capacity 300 ml. 3.3.4 Rinse fluid, prepared by dissolving 3 g of commercially available highly concentrated polysorbate 80 (Tween 80) in 10 l of purified water (grade 1 or grade 2 as specified in ISO 3696). 3.3.5

40、 Equipment for supplying the rinse fluid under a suitable pressure, including a terminal filter with a maximum pore size of 1,2 m. 3.3.6 Microscope, magnification about 50, with suitable direct illumination at an angle of 0 to 10 with the microscope stage. 3.4 Preparation for the test 3.4.1 Ensure t

41、hat the environment in which the test is to be carried out is free from extraneous particles which could cause interference. This involves wearing suitable garments and gloves and using a suitable clean-air work station, for example a laminar-flow cabinet meeting the requirements of Class 8 of ISO 1

42、4644-1 (Class 100,000 of US Federal Standard 209E), as well as suitably decontaminated tools and sample-handling equipment. 3.4.2 Carry out a blank test, as follows: Place 50 ml of filtered rinse fluid in a conical flask. Shake for 20 s. Immediately filter the fluid through a membrane filter. Add an

43、other 50 ml portion of rinse fluid to the flask, shake, and filter in the same way. Transfer the filter to the microscope, taking care not to contaminate it. Count the particles on the filter. No more than five particles of Class I and no more than one particle of Class II shall be found. No particl

44、es of Class III shall be present. ENISO88713:2004 3If these requirements are not met, investigate the possible causes of failure, rectify, and repeat the blank test until satisfactory results are obtained. Carry out a blank test both before and after each series of tests. Only when satisfactory valu

45、es are obtained both before and after the series of tests can the results of the tests be considered valid. 3.5 Test Place a number of complete elastomeric parts with a total surface area of approximately 100 cm 2into a conical flask. Add 50 ml of filtered rinse fluid. Shake for 20 s. Immediately fi

46、lter the fluid through a membrane filter. Add another 50 ml portion of rinse fluid to the flask, shake and filter in the same way. Transfer the filter to the microscope, taking care not to contaminate it. Count the particles on the filter. 3.6 Test report For each test, report the following: a) the

47、total surface area of the elastomeric parts tested, and the number of complete parts tested; b) the total particle count in each of the three particle-size classes; c) the particle counts in each of the three classes for the blank tests performed; d) the average particle count in each class per 10 cm 2of surface, rounded to one place of decimals. 4 Determination of subvisible-particle count 4.1 Principle In contact with liquid pharmaceutical preparations, elastomeric parts may release particles having dimensions of 25 m or smaller, and hence not visible to the naked eye. Their

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1